KJT Welcomes New VP of Qual, Marilisa Beatty

KJT Welcomes New VP of Qual, Marilisa Beatty

KJT is thrilled to announce the newest addition to our team, Marilisa Beatty, who will be joining the team as a Vice President of Qualitative Research.

Marilisa is a dynamic qualitative researcher with more than 15 years of experience in global healthcare research. Her expertise has helped shape strategy for leading pharmaceutical brands worldwide, as well as for emerging biotech companies. Marilisa is known for her adept problem-solving skills, innovative approaches to research, and her personable rapport during interviews among healthcare professionals, patients, and caregivers.

In her new position at KJT, Marilisa will lead the qualitative research department, leveraging her expertise to enhance our patient-centered evidence generation and ensure the highest quality of insights for our clients. Her role will be critical in pushing the boundaries of healthcare research and in reinforcing KJT’s commitment to take research further, together.

“Marilisa’s vast expertise in qualitative research is exactly what KJT needs to continue excelling in our field.” said Michaela Gascon, President and CEO of KJT. “Her visionary approach will undoubtedly enrich our capabilities and enhance our position as industry leaders in healthcare. We look forward to the significant contributions she will bring to our company’s and our clients’ growth and success.”

Blogs & News

Read More
Read More

Unlocking Participant Engagement: The Key to Meaningful Market Research

In pharmaceutical market research, one element remains consistently crucial: participant…

Read More
Read More

Navigating Successful Real-World Evidence Publications: An Interdisciplinary Journey

Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…

Read More
Read More

Go from Exam Room Conversations to Actionable Healthcare Insights

Understanding what goes on in the exam room between patients and HCPs remains a critical yet…

Read More
Read More

Patient Voice Isn’t Optional, It’s the Future of RWE

Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…

Read More
Read More

4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

Synthetic data is not new to market research, and the healthcare insights industry is starting to…

Read More
Read More

Beyond the Hype: How Digital Twins Are Transforming Market Research

Digital twins are reshaping the way we generate insights across industries. In this webinar, we…

Read More
Read More

5 Takeaways from an Intellus Newbie

Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…

Read More
Read More

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

Building the Future: Why Qualitative Insights Will Thrive in the Age of AI

AI is transforming the way we collect and analyze qualitative data—but rather than replacing…

Let’s Take Research Further. Together.